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with condoms only (adjusted odds ratio,
[AOR] = 3.01; 95% conﬁdence interval
[CI] = 1.96 to 4.64) and less likely to
prefer both methods compared with condoms only (AOR = 0.63; CI = 0.45 to
0.89). Men from Fort Lauderdale (vs.
Chicago) were less likely to prefer PrEP
compared with condoms (P , 0.05). No
differences were found for race/ethnicity,
age, or education in regression models for
the full sample (P . 0.05).
In stratiﬁed multivariable analyses
by risk behavior (Table 1), among participants who reported recent anal sex
without a condom, men aged 18–29 (vs.
40+) were less likely to prefer PrEP
compared with condoms only (AOR =
0.42; CI = 0.22 to 0.77) and more likely
to prefer both methods compared with
condoms only (AOR = 2.44; CI = 1.30 to
4.58). Men from Fort Lauderdale (vs.
Chicago) were less likely to prefer PrEP
compared to condoms within both subgroups of men who did and did not report
recent risk behavior (P , 0.05). No other
within-group demographic differences
were found.
Although several demographic and
risk behavioral differences in prevention
method preferences were observed for
the sample in bivariate analyses, differences in multivariable regression analyses were narrowed to MSM reporting
recent risk behavior and Fort Lauderdale
residence when controlling for other
demographic characteristics. Speciﬁcally,
MSM reporting recent risk behavior preferred PrEP to condoms and were less
likely to prefer using both methods over
condoms, compared with men not reporting risk behavior. It is unsurprising that
MSM not using condoms would be more
likely to prefer using PrEP to condoms,
which represents an increase in protection
for these individuals. At the same time,
condom users preferred additional protection in conjunction with condoms,
which also represents an increase in
protection for those individuals. The
increased protection among condom
users and nonusers does not support the
concern of risk compensation.
Of keen interest is that among the
MSM who reported recent risk behavior,
younger men were more likely to prefer
using both methods over condoms alone,
which would provide additional protection
to this group at particularly high risk of

HIV infection.1 Simultaneously, older men
with recent risk behavior preferred PrEP
over condoms. Geographical differences
in preferences were also noteworthy.
This cross-sectional analysis is limited in that it assessed prevention method
preferences and not actual behavior over
time. Furthermore, preferences for using
PrEP in the future obviously do not take
into account adherence and uptake,
although we do know about recent condomless anal sex and we included that
consideration in this analysis. The study
is limited to black and Latino MSM at
highest risk for infection. Further research
is needed on these populations in US
cities beyond those represented here and
with diverse samples of MSM.
More black and Latino MSM preferred using both PrEP and condoms to
either method singularly, especially
younger men. This ﬁnding is contrary
to a concern of risk compensation.5 This
study reports promising potential for
enhanced protection with PrEP among
both current condom users and nonusers.
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Letters to the Editor

condomless intercourse refers to sexual
intercourse without a condom timed to
peak fertility during ovulation and/or in
combination with antiretroviral therapy
(ART) in the HIV-infected partner and/
or PrEP for the uninfected partner.
To the Editors:
HIV-infected individuals are living
longer, more productive lives. HIVaffected individuals and couples experience personal and social desires to
reproduce for all the same reasons as
uninfected individuals and couples,1 and
thus require safe reproductive options.
HIV prevention interventions often do
not consider the childbearing desires of
HIV-affected individuals or couples, especially in low- and middle-income countries
(LMICs). Failure to assist women with
desired fertility can contribute to continued
HIV transmission and must be addressed
within national elimination of mother-tochild transmission (eMTCT) strategies.
A human rights perspective suggests
that HIV-affected couples* should have
the same ability to choose if and when to
have children as HIV-unaffected couples,
including access to pre-pregnancy
counseling, contraceptives, and, when

FIGURE 1. Redefining
strategy.
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needed, abortion services. This holistic
view includes assistance in mitigating
HIV transmission risk when children are
desired. In high-income countries, HIVaffected individuals and couples have
access to an array of options: (1) treatment of the HIV-infected partner as prevention of transmission to the uninfected
partner in conjunction with timed condomless intercourse2**; (2) preexposure
prophylaxis (PrEP) for the uninfected
partner3; (3) assisted reproductive services, including timed vaginal insemination and sperm washing with intrauterine
insemination or in-vitro fertilization4,5;
(4) sperm donation; and (5) adoption.1,6
In contrast, access to methods of
becoming pregnant in LMICs are limited
by cost, availability, and sometimes a lack
of appreciation by policymakers of the
desires and rights of HIV-affected individuals/couples to have children safely.
Simple fertility methods may not be
discussed as a component of routine
HIV care and treatment counseling due to
a lack of awareness or knowledge about
their safety, affordability, or efﬁcacy.7 To
enhance the armamentarium of HIV prevention and reproductive services to
achieve zero perinatal and sexual transmission, “safer conception”, and fertility

services should be integrated into existing
PMTCT strategies.
The existing four-pronged prevention of mother-to-child transmission
(PMTCT) strategy, developed by the
World Health Organization (WHO), includes (1) prevention of HIV in women
of reproductive age; (2) prevention of
unintended pregnancy in women with
HIV; (3) prevention of HIV transmission
from mother to child; and (4) the provision of ongoing care and support to
mothers, their children, and their families.8 All four prongs are rooted in prevention of sexual and perinatal HIV
transmission, HIV testing, use of ART
for mothers and infants, exclusive breastfeeding, and access to contraceptive
services. The continuum of care services
are included within the third WHO
prong, including antenatal, intrapartum,
and postpartum/postnatal health care
services (Fig. 1). However, provision of
education and clinical services for achieving pregnancy safely is not uniquely
addressed in the current WHO eMTCT
strategy,8 and we believe that they should
be included within the continuum of care
services of the third prong of the strategy
that addresses: “prevention of HIV transmission from mother to child.”

the prevention/eMTCT
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Interventions for Achieving Pregnancy Safely in HIV-Affected Couples*

High-income country†
Low- and middle-income
country†
♂+/♀−§
♂−/♀+§
Estimated risk reduction

Treatment as Prevention
With Timed Condomless
Intercourse

PrEP

SW-IUI

TVI

Environment
d
d

d
‡

d
‡

d
d

HIV-serodiscordant couple
d
d
95%2

d
d
63%–73%3

d
100%4,5

d
100%

*Screening and treatment of sexually transmitted diseases decrease the risk of HIV transmission/acquisition,
estimated risk reduction up to 40%.
†World Bank Classiﬁcation.
‡Not readily available in low- and middle-income country prepared by Sarah Block.
§HIV viral RNA suppression should be assured, if possible.
SW-IUI, sperm washing with intrauterine insemination; TVI, timed vaginal insemination.

NEW KNOWLEDGE ON SAFER
PRE-PREGNANCY OPTIONS AS
HIV INTERVENTIONS
In order to broaden our reach in HIV
prevention, we propose this new approach
within the existing prevention strategy to
expand fertility service options that will
address all the reproductive desires of
HIV-affected individuals and couples.
They need positive guidance and support
from health care providers to minimize
sexual HIV transmission. Without this
assistance in achieving pregnancy safely,
HIV-affected individuals and couples risk
HIV transmission to the uninfected partner,
especially in the absence of ART, viral
suppression, and/or PrEP.9 The eMTCT
spectrum of care provides an ideal construct for the inclusion of pre-pregnancy
services particularly when engagement of
the male partner is achieved to reduce the
risk of HIV transmission to the uninfected
partner and developing fetus. To achieve
this, advocacy groups will also need to call
for policy changes to include the integration of couples counseling and fertility
service options for achieving pregnancy
safely into existing HIV care and prevention strategies.

PROBLEM TO BE ADDRESSED
More than 35 million people worldwide live with HIV, and up to 60% of
new HIV infections occur in HIVserodiscordant partnerships.10,11 In Kenya alone, there are an estimated 260,000
HIV-serodiscordant couples.12 In order to

reduce mother-to-child transmission in
Kenya to below 5% by the end of
2015, greater than 90% of HIVinfected women need to be identiﬁed,
treated with ART, and offered other
HIV prevention interventions.13 The
assurance of comprehensive reproductive care services that addresses the
spectrum of reproductive health care
needs across an HIV-infected individual’s life cycle is a component that
is missing from current programs,
largely due to the ignorance of their
value as essential to reducing heterosexual and subsequent vertical transmission of HIV.
Before expanded access to effective ART, health care providers actively
discouraged HIV-affected women from
becoming pregnant.14 Although ART
is now more accessible in sub-Saharan
Africa, one report documented that less
than half of known HIV-infected individuals in Kenya achieved viral suppression
(ie, HIV RNA ,1000 copies).12 Similarly,
only 30% of all HIV-infected individuals
in the United States are virally suppressed
as per the most recent estimates.15
Despite the shift in reproductive
guidelines supporting pregnancy in HIVaffected persons,16–21 most health care
facilities in sub-Saharan Africa do
not offer safer options for couples
attempting to become pregnant.22,23
HIV-infected women who express a desire
for children often encounter the disapproval of their communities and/or health
care workers.23

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.

COMPREHENSIVE
eMTCT/PMTCT STRATEGY
Incorporating pre-pregnancy and
“safer conception” services into eMTCT
(Fig. 1) allows healthy HIV-affected
individuals to choose to achieve their
reproductive goals of childbearing
while minimizing risks of HIV transmission from or to their uninfected partners.
Lower-cost assisted fertility interventions
for achieving pregnancy safely include
initiation of lifelong ART for the HIVinfected partner and/or PrEP for the HIVuninfected partner. Other approaches
include timed vaginal insemination or
sperm washing with intrauterine insemination. To achieve success in global HIV
prevention, a combination of interventions
incorporating behavioral and biomedical
interventions are required. Hence, treatment as prevention (ie, starting ART to
prevent HIV transmission) coupled with
timed condomless intercourse, with or
without PrEP, should not be the only
option for HIV-affected individuals and
couples desiring children. These interventions require continued engagement
in care—adherence to ART and/or
PrEP as well as HIV viral load monitoring for the HIV-infected partner
(Table 1). Regardless, the goals for
reproductive health programs for HIVserodiscordant couples need to both
help protect the HIV-uninfected partner
while ensuring the autonomy of the
HIV-infected partner through the use
of multiple options to achieve pregnancy safely. Finally, to address HIVrelated stigma and close the gap in
health care services, health care providers
must be equipped with training, educational materials, and the clinical supplies
required to provide safer pre-pregnancy
services for HIV-affected couples
desiring children.
Prevention of HIV transmission
to the uninfected male partner in
female-positive
HIV-serodiscordant
couples is critical to ensuring male
partner involvement and improved success of eMTCT interventions at the
community level.24 In sub-Saharan
Africa, men possess social and economic power, and often play a major
role in their partners’ health decision
making.25 For example, successful
uptake and integration of contraceptive
services into HIV care and treatment in
www.jaids.com |
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Kenya was accelerated by the acceptance and participation of the male
partner.26 Similarly, the extent to
which male partner involvement can
facilitate the uptake and adaptation of
pre-pregnancy
services
requires
research within the eMTCT strategy.27

FUTURE DIRECTIONS
Achieving the ambitious goal of
zero HIV transmission to unborn children and sexual partners requires
enhancement of the existing eMTCT
strategy. To achieve this, advocacy
groups need to call for policy changes
that integrate couples counseling and fertility service options into existing HIV care
and prevention strategies. An interdisciplinary approach, inclusive of health care
providers and administrators, policy makers, laboratory staff, researchers, donors,
and community members, is critical to the
integration and acceptance of lower cost
and safer reproductive options into the
eMTCT strategy for HIV-affected couples
desiring children.28,29 These stakeholders should work together to promote
the development of evidence-based
clinical guidelines to support and integrate reproductive services into HIV
care and treatment programs. At any
given time along the reproductive
spectrum, safer conception options
must be recognized as a critical priority
element of any comprehensive “family
planning” initiative that are currently
viewed only through the prism of
contraception, child spacing, and
access to safe abortion.
We encourage support for research
on, and implementation of, safer prepregnancy interventions, including
funding for the development and dissemination of educational training materials
for health care providers that are relevant to LMICs.22 In the changing context of ART initiation guidelines, we
must accept that some HIV-infected
individuals will make the choice to
delay ART.30,31 Respecting their autonomy and decision making requires the
provision of safer pre-pregnancy options that may include ART and/or
PrEP. Recognition and support of the
childbearing desires and reproductive
rights of HIV-affected individuals and
couples require that fertility services be
made accessible, affordable, and inte-
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grated into the prevention and eMTCT
care continuum.
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